IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Protagonist Therapeutics Inc

CUSIP: 38141G107 | 1 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Twin Lakes Capital Management, LLC58,059
2.7% of portfolio›$7.1M
StyleTurnoverLocationFiled
Twin Lakes Capital Management, LLC
58,059$7.1M2.7%GrowthLowRedwood Shores, CA2026-08-18